-
Something wrong with this record ?
Antimicrobial and cytotoxic activity of (thio)alkyl hexopyranosides, nonionic glycolipid mimetics
P. Džubák, S. Gurská, K. Bogdanová, D. Uhríková, N. Kanjaková, S. Combet, T. Klunda, M. Kolář, M. Hajdúch, M. Poláková,
Language English Country Netherlands
Document type Journal Article
Grant support
NV16-32302A
MZ0
CEP Register
- MeSH
- Anti-Bacterial Agents chemical synthesis chemistry pharmacology MeSH
- Cell Line MeSH
- A549 Cells MeSH
- K562 Cells MeSH
- X-Ray Diffraction MeSH
- Enterococcus faecalis drug effects MeSH
- Galactose chemical synthesis chemistry pharmacology MeSH
- Glycosides chemical synthesis chemistry pharmacology MeSH
- HCT116 Cells MeSH
- Humans MeSH
- Lipid Bilayers chemistry MeSH
- Scattering, Small Angle MeSH
- Microbial Sensitivity Tests MeSH
- Molecular Structure MeSH
- Cell Proliferation MeSH
- Antineoplastic Agents chemical synthesis chemistry pharmacology MeSH
- Carbohydrate Sequence MeSH
- Cell Survival drug effects MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
A series of 19 synthetic alkyl and thioalkyl glycosides derived from d-mannose, d-glucose and d-galactose and having C10-C16 aglycone were investigated for cytotoxic activity against 7 human cancer and 2 non-tumor cell lines as well as for antimicrobial potential on 12 bacterial and yeast strains. The most potent compounds were found to be tetradecyl and hexadecyl β-d-galactopyranosides (18, 19), which showed the best cytotoxicity and therapeutic index against CCRF-CEM cancer cell line. Similar cytotoxic activity showed hexadecyl α-d-mannopyranoside (5) but it also inhibited non-tumor cell lines. Because these two galactosides (18, 19) were inactive against all tested bacteria and yeast strains, they could be a target-specific for eukaryotic cells. On the other hand, β-D-glucopyranosides with tetradecyl (11) and hexadecyl (12) aglycone inhibited only Gram-positive bacterial strain Enterococcus faecalis. The studied glycosides induce changes in the lipid bilayer thickness and lateral phase separation at high concentration, as derived from SAXS experiments on POPC model membranes. In general, glucosides and galactosides exhibit more specific properties. Those with longer aglycone show high cytotoxicity and therefore, they are more promising candidates for cancer cell line targeted inhibition.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028540
- 003
- CZ-PrNML
- 005
- 20211209131648.0
- 007
- ta
- 008
- 210105s2020 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.carres.2019.107905 $2 doi
- 035 __
- $a (PubMed)32004953
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Džubák, Petr $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 5, 779 00, Olomouc, Czech Republic.
- 245 10
- $a Antimicrobial and cytotoxic activity of (thio)alkyl hexopyranosides, nonionic glycolipid mimetics / $c P. Džubák, S. Gurská, K. Bogdanová, D. Uhríková, N. Kanjaková, S. Combet, T. Klunda, M. Kolář, M. Hajdúch, M. Poláková,
- 520 9_
- $a A series of 19 synthetic alkyl and thioalkyl glycosides derived from d-mannose, d-glucose and d-galactose and having C10-C16 aglycone were investigated for cytotoxic activity against 7 human cancer and 2 non-tumor cell lines as well as for antimicrobial potential on 12 bacterial and yeast strains. The most potent compounds were found to be tetradecyl and hexadecyl β-d-galactopyranosides (18, 19), which showed the best cytotoxicity and therapeutic index against CCRF-CEM cancer cell line. Similar cytotoxic activity showed hexadecyl α-d-mannopyranoside (5) but it also inhibited non-tumor cell lines. Because these two galactosides (18, 19) were inactive against all tested bacteria and yeast strains, they could be a target-specific for eukaryotic cells. On the other hand, β-D-glucopyranosides with tetradecyl (11) and hexadecyl (12) aglycone inhibited only Gram-positive bacterial strain Enterococcus faecalis. The studied glycosides induce changes in the lipid bilayer thickness and lateral phase separation at high concentration, as derived from SAXS experiments on POPC model membranes. In general, glucosides and galactosides exhibit more specific properties. Those with longer aglycone show high cytotoxicity and therefore, they are more promising candidates for cancer cell line targeted inhibition.
- 650 _2
- $a buňky A549 $7 D000072283
- 650 _2
- $a antibakteriální látky $x chemická syntéza $x chemie $x farmakologie $7 D000900
- 650 _2
- $a protinádorové látky $x chemická syntéza $x chemie $x farmakologie $7 D000970
- 650 _2
- $a sacharidové sekvence $7 D002240
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a proliferace buněk $7 D049109
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a Enterococcus faecalis $x účinky léků $7 D013293
- 650 _2
- $a galaktosa $x chemická syntéza $x chemie $x farmakologie $7 D005690
- 650 _2
- $a glykosidy $x chemická syntéza $x chemie $x farmakologie $7 D006027
- 650 _2
- $a HCT116 buňky $7 D045325
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a buňky K562 $7 D020014
- 650 _2
- $a lipidové dvojvrstvy $x chemie $7 D008051
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a maloúhlový rozptyl $7 D053838
- 650 _2
- $a difrakce rentgenového záření $7 D014961
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Gurská, Soňa $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 5, 779 00, Olomouc, Czech Republic. $7 xx0267298
- 700 1_
- $a Bogdanová, Kateřina $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 5, 779 00, Olomouc, Czech Republic.
- 700 1_
- $a Uhríková, Daniela $u Department of Physical Chemistry of Drugs, Faculty of Pharmacy, Comenius University in Bratislava, Odbojarov 10, 832 32, Bratislava, Slovakia.
- 700 1_
- $a Kanjaková, Nina $u Department of Physical Chemistry of Drugs, Faculty of Pharmacy, Comenius University in Bratislava, Odbojarov 10, 832 32, Bratislava, Slovakia.
- 700 1_
- $a Combet, Sophie $u Laboratoire Léon Brillouin (CEA/CNRS), CEA Saclay, 91191, Gif-sur-Yvette Cedex, France.
- 700 1_
- $a Klunda, Tomáš $u Institute of Chemistry, Center for Glycomics, Slovak Academy of Sciences, Dubravska cesta 9, SK-845 38, Bratislava, Slovakia.
- 700 1_
- $a Kolář, Milan $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 5, 779 00, Olomouc, Czech Republic.
- 700 1_
- $a Hajdúch, Marian $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 5, 779 00, Olomouc, Czech Republic. Electronic address: marian.hajduch@upol.cz.
- 700 1_
- $a Poláková, Monika $u Institute of Chemistry, Center for Glycomics, Slovak Academy of Sciences, Dubravska cesta 9, SK-845 38, Bratislava, Slovakia. Electronic address: Monika.Polakova@savba.sk.
- 773 0_
- $w MED00001049 $t Carbohydrate research $x 1873-426X $g Roč. 488, č. - (2020), s. 107905
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32004953 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20211209131647 $b ABA008
- 999 __
- $a ok $b bmc $g 1608875 $s 1119720
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 488 $c - $d 107905 $e 20191228 $i 1873-426X $m Carbohydrate research $n Carbohydr Res $x MED00001049
- GRA __
- $a NV16-32302A $p MZ0
- LZP __
- $a Pubmed-20210105